Publications

Published papers:

• Hauser MA, Li Y-J, Takeuchi S, Walters R, Noureddine M, Maready M, Darden T, Hulette C, Martin E, Hauser E, Xu H, Schmechel D, Stenger JE, Dietrich F, Vance JM (2003) Genomic Convergence: Identifying candidate genes for Parkinson disease by combining serial analysis of gene expression (SAGE) and genetic linkage. Hum Mol Genet 12:671-676

• Hulette CM (2003) Brain Banking in the United States. (Invited Review) J Neuropathol Exp Neurol. 2003;62

• Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH, Jr., Scott BL, Goetz CG, Small GW, Mastaglia, F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM (2003) Parkin mutations and susceptibility alleles in late-onset Parkinson Disease.  Ann Neurol 53:624-629

• Trembath Y, Rosenberg C, Ervin JF, Schmechel DE, Gaskell P, Pericak-Vance M, Vance J, Hulette CM (2003) Familial Lewy body Pathology is a Frequent Co-pathology in Familial Alzheimer Disease. Acta Neuropathol 105:484-488

• van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM (2003) Mitochondrial polymorphisms significantly reduce risk of Parkinson disease. Am J Hum Genet 72:804-811

• van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, Vance JM (2003)  Genetic Polymorphisms of the N-acetyltransferase genes (NAT1 and NAT2) and risk to Parkinson’s Disease.  Neurology 60:1189-1191

• Oliveira SA, Martin ER, Scott WK, Nicodemus KK, Small GW, Schmechel DE, Doraiswamy PM, Roses AD, Saunders AM, Gilbert JR, Haines JL, Vance JM, and Pericak-Vance MA (2003) The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease. Neurosci.Lett. 347 (3):143-146

• Oliveira SA, Scott WK, Martin ER, Pericak-Vance MA, Vance JM. Frequency of Parkin mutations in late-onset Parkinson disease [reply]. Letter to the Editor, Annals of Neurology 2003; 54:416-417.

• Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Scott BL, Goetz CG, Small GW, Masterman D, Haines JL, Pericak-Vance MA, Vance JM, Martin ER (2003) Association Study of Parkin Gene Polymorphisms with Idiopathic Parkinson Disease.  Arch Neurol 60(7): 975-980.

• Fessel JP, Hulette C, Powell S, Roberts LJ, and Zhang J (2003) Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease.  J.Neurochem. 85 (3):645-650.

• Hulette CM (2003) Brain banking in the United States. J.Neuropathol.Exp.Neurol. 62 (7):715-722

• Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER (2003) A genotype-based association test for general pedigrees: The genotype-PDT. Genet Epidemiol 25(3): 203-213.

• Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, VANCE JM, Pericak-Vance MA.  (2003) Glutathione S-Transferase Omega 1 modifies age-at-onset of Alzheimer Disease and Parkinson Disease. Hum Mol Genet. 12(24): 3259-67.

• Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao T-P.  The deacetylase HDAC6 regulates aggesome formation and cell viability in response to misfolded protein stress.  Cell 115(6): 727-738, 2003.

• Li Y-J, Hauser MA, Scott WK, Martin ER, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner CB, Jankovic J, Goetz CG, Small GW, Mastaglia F, Booze MW, Haines JL, Pericak-Vance MA, Vance JA (2004) Apolipoprotein E controls the risk and age at onset of Parkinson Disease. Neurology 62(11): 2005-2009.

• van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, Mckay R, Zhang F, Stajich JM, Fujiwara K, Hauser MA, Scott BL, Pericak-Vance MA,  Vance JM, Martin ER. (2004) Fibroblast Growth Factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. American Journal of Human Genetics, 74(6): 1121-7.

• Saito Y, Suzuki K, Hulette CM, Murayama S.  Aberrant Phosphorylation of α-Synuclein in Human Niemann-Pick Type C1 Disease.  (2004) Journal of Neuropathology and Experimental Neurology 63(4): 323-328.

• Oliveira SA, Scott WK, Zhang F, Stajich JM, Fujiwara K, Hauser M, Scott BL, Pericak-Vance MA, Vance JM, Martin ER.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.  Neurogenetics. 5(3): 147-55, 2004.

• Hauser MA, Li Y-J, Xu H, Stenger JE, Noureddine MA, Shao Y, Gullans SR, Schertzer CR, Jensen RV, McLaurin AC, Scott BL, Jewett RM, Hulette CM, Schmechel DE, Vance JM. Expression Profiling of Substantia Nigra in Parkinson, PSP, and FTDP-17. Archives of Neurology, 62(6):917-21, 2005.

• Noureddine MA, Qin X-J, Oliveira SA, Skelly TA, van der Walt JM, Hauser MA, Pericak Vance MA, Vance JM, Li Y-J.  Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease.  Human Genetics, 117(1):27-33, 2005.

• Stenger JE, Xu H, Haynes C, Hauser ER, Pericak-Vance MA, Goldschmidt-Clermont PJ and        Vance JM.  Statistical Viewer: A Tool for Uploading and Integrating Linkage and Association     Data into the Ensembl Genome Browser for Display as Plots in "Contig View" and "Cyto View".  BMC Bioinformatics, 6(1):95, 2005.

• Oliveira S, Li Y, Noureddine M, Zuchner S, Qin X, Pericak Vance MA, Vance JM, Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.  American Journal of Human Genetics, 77(2):252-64, 2005.

• Scott WK, Zhang F, Stajich JM, Scott BL, Stacy MA, Vance JM. Family-based case-control study of cigarette smoking and Parkinson disease. Neurology. 63(3): 442-7, 2005.

• Noureddine MA, Li, Y-J van der Walt JM, Walters R,  Jewett RM, Xu H, Wang T, Walter J, Scott BL, Hulette C, Schmechel D, Stenger J, Dietrich F, Vance JM, and  Hauser MA.  Genomic Convergence to identify candidate genes for Parkinson disease:  SAGE analysis of the Substantia nigra.  Mov Disord. 2005 Oct;20(10):1299-309.

• Kang SJ, Scott WK, Li YJ, Hauser MA, van der Walt JM, Fujiwara K, Mayhew GM, West SG, Vance JM, Martin ER.  Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. Mov Disord. 2006 Dec;21(12):2175-80.

• Li YJ, Scott WK, Zhang L, Lin PI, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, Pericak-Vance MA, Vance JM. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiological Aging, 2006 Aug;27(8):1087-93. 

• Hancock DB, Martin ER, Fujiwara K, Stacy MA, Scott BL, Stajich JM, Jewett R, Li YJ, Hauser MA, Vance JM, Scott WK.  NOS2A and the modulating effect of cigarette smoking in Parkinson disease. Ann Neurol. 2006 Sep;60(3):366-73.

• Golbe LI, Di Iorio G, Markopoulou KM, Athanassiadou A, Papapetropoulos S, Watts RL, Vance JM, Bonifati V, Williams TA, Spychala JR, Stenroos ES, Johnson WG. Glutathione S-transferase polymorphisms and onset age in α-synuclein A53T mutant Parkinson's disease.  Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144(2):254-8.

• Scherzer CR, Eklund AC, Morse LJ, LiaoZ, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growndon JH, Jensen RV, Gullarns SR.  Molecular markers of early Parkinson's disease based on gene expression in blood.  Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):955-60.

• Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Janin S, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Scott WK, Klein C, Brice A, Roomere H, Ottman R, Marder K.  Construction and validation of a Parkinson’s disease mutation genotyping array for the Parkin gene. Movement Disorders. 2007 May 15;22(7):932-7.

• Lin PI, Vance JM,  Pericak-Vance MA, Martin ER.  No gene is an island: the flip-flop phenomenon. AJHG 80:531-538, 2007.

• Hancock, DB, Martin ER, Stajich JM, Jewett R, Stacy MA, Scott BL, Vance JM, Scott WK.  Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson's disease.  Arch Neurol. 2007 Apr;64(4):576-80.

• Hancock DB, Scott WK.  Population-based case-control association studies. Curr Protoc Hum Genet.  2007 Jan;Chapter 1:Unit 1.17.

• Hancock DB, Martin ER, LiYJ, Scott WK.  Methods for interaction analyses using family-based case-control data:  conditional logistic regression versus generalized estimating equations.  Genet Epidemiol (2007) 31:883-93.

• Li, YJ, Deng J, Mayhew GM, Grmisley JW, Huo X, Vance JM.    Investigation of the   PARK10 gene in Parkinson Disease.  Annals of Human Genetics, in press, 2007.

• Nelson S, Hale AB, Granger CB, Haines JL, Jones CJ, Crossman D, Seo D, Gregory Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet. 2007 Mar;80(3):531-8. Erratum in: Am J Hum Genet. 2007 May;80(5):1002.

• Hancock DB, Martin ER, Vance JM, Scott WK. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease, Neurogenetics 2008 Jul 29. [Epub ahead of print].

• Hancock DB, Martin ER, Mayhew GM, Stajich JM, Jewett R, Stacy MA, Scott BL , Vance JM, Scott WK.  Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol. 2008 Mar 28;8:6.

• Gao X, Scott WK, Wang G, Mayhew G, Li YJ, Vance JM, Martin ER. Gene-gene interaction between FGF20 and MAOB in Parkinson disease. Ann Hum Genet. 2008 Mar;72(Pt 2):157-62.

• Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, Martin ER, Vance JM.Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet. 2008 Feb;82(2):283-9. 

• Gao X, Starmer J, Martin ER. (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genetic Epidemiol. Feb. 12; [Epub ahead of print].

• Zhang L, Li Y-J, Chung RH, Martin ER, Morris R.. (2008) X-LRT: A likelihood approach to estimate genetic risks and test association with x-linked markers using a case-parents design. Genetic Epidemiol.  May;32(4):370-380.

• Chung RH, Morris RW, Li Z, Li Y-J, Martin ER. (2007) X-APL: An improved family-based test of association for the X chromosome. Am J Hum Genet. 2007 Jan;80(1):59-68.

• Ewens WJ, Spielman RS, Kaplan NL, Gao X, Morris RW, Martin ER.  (2008)  Disease associations and family-based tests.  Curr Protoc Hum Genet 2008 Jul;Chapter 1:Unit 1.12.

Abstracts:

Scott WK, Stajich JM, Scott BL, Rogala AR, Booze MW, Ribble RC, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Pahwa R, Stern MB, Colcher A, Hiner BC, Allen FH, Goetz CG, Pappert EJ, Small GW, Masterman D, Mastaglia F, Laing NG, Middleton LT, Roses AD, VANCE JM, Pericak-Vance MA.  Complete genomic screen in familial Parkinson disease.  Neurology 56(Suppl.3): A133, April 2001.

• Scott WK, Stajich JM, Scott BL, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FH, Goetz CG, Small GW, Mastaglia F, Middleton LT, Roses AD, VANCE JM, Pericak-Vance MA. Complete Genomic Screen in Idiopathic Parkinson Disease. American Society of Human Genetics Meeting, San Diego, CA, October 12-16, 2001. American Journal of Human Genetics, 69(4): 1943A, 2001.

• Oliveira SA, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Hauser MA, Middleton LT, Roses AD, Haines JL, Scott BL, Pericak-Vance MA, VANCE JM. Association of Tau with Late-Onset Parkinson Disease. American Society of Human Genetics Meeting, San Diego, CA, October 12-16, 2001. American Journal of Human Genetics, 69(4): 1932A, 2001.

• Hauser MA, Maready M, Takeuh S, Dai HH, Hulette CM, Stajich JE, Rosenberg C, Stajich JM, Hauser ER, Martin ER, VANCE JM. Identification of candidate genes for Parkinson Disease (PD) by profiling gene expression in the substantia nigra. American Society of Human Genetics Meeting, San Diego, CA, October 12-16, 2001. American Journal of Human Genetics, 69(4): 2234A, 2001.

• VANCE JM, Y. Li, F. Zhang, M. W. Booze, E. R. Martin, W. K. Scott, J. L. Haines, M. A. Nance, J. P. Hubble, W. C. Koller, R. Pahwa, M. Stern, B. C. Hiner, J. Jankovic, C. G. Goetz, G. W. Small, F. Mastaglia, R. A. Gibson, L. T. Middleton, M. A. Pericak-Vance.  Apolipoprotein E Controls The Risk And Age At Onset Of Parkinson Disease. ASHG, 2002.

• Hulette CM, Szymanski M, Jewett R, Schmechel DE, VANCE JM. Rapid Brain Autopsy for Parkinson Disease Research. 55th Annual Meeting of the American Academy of Neurology, March 2003.

• Oliveira SA, Zhang F, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Stajich JM, Middleton LT, Haines JL, Scott BL, Pericak-Vance MA, VANCE JM, Martin ER. Characterization of Tau with Parkinson Disease. Submitted to American Neurological Association 128th Annual Meeting and the 6th Annual Neurology Outcomes Symposium, 2003.

• Li YJ, Oliveira S, Xu P, Martin ER, Stenger J, Scott WK, Hauser MA, Scherzer C, Smal G, Nance M, Watts R, Hubble J, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel  DE, Welsh-Bohmer KA, Hulette C, Gullans SR, Haines JL, Gibert JR, VANCE JM, Pericak-Vance MA. Glutathione S-Transferase modifies age at onset of Alzheimer Disease. 55th Annual Meeting of the American Academy of Neurology. Neurology 60(5) Supplement 1: 68A-69A, 2003.

• Li YJ, Martin ER, Scott WK, Haines JL, Nance MA, Hubble JP, Hiner BC, Jankovic J, Goetz CG, Small GW, Gibson RA, Middleton LT, VANCE JM. Apolipoprotein E Controls Risk and Age at Onset of Parkinson Disease. 55th Annual Meeting of the American Academy of Neurology. Neurology 60(5) Supplement 1:127A-128A, 2003.

• van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Haines JL, McLaurin AC, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Gibson RA, Middleton LT, Pericak-Vance MA, VANCE JM. Specific Mitochondrial Hapligroups Affect Risk for Late-Onset Parkinson Disease. 55th Annual Meeting of the American Academy of Neurology. Neurology 60(5) Supplement 1:438A, 2003.

• Golbe LI, Di Iorio G, Markopoulou AM, Athanassiadou A, Papapetropoulos S, Watts RL, Vance JM, Bonifati V, Stenroos ES, Johnson WG. Glutathione S-transferase genetic defect as a modifier of the phenotype of PD caused by the A53T alpha-synuclein mutation. American Academy of Neurology, San Francisco, CA, April 24-May 1, 2004.

• Oliveira AS, Chromosome 1 association map to identify gene(s) associated with age-at-onset and risk for Parkinson disease.  European Conference of Human Genetics, Munich, Germany, June 12-15, 2004.

• Noureddine M, Qin X, Hauser M, Pericak-Vance M, Vance JM, Li Y. Significant association between single-nucleotide polymorphisms in the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. 8th International Congress of Parkinson Disease and Movement Disorder Society Rome, Italy, June 13-17, 2004.

• Scott WK, Zhang L, Stajich JM, Scott B, Stacy M, Vance JM.  Pesticide use and risk of Parkinson disease: a family-based case-control study. 8th International Congress of Parkinson Disease and Movement Disorder Society Rome, Italy, June 13-17, 2004.

• van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, Mckay R, Zhang F, Stajich JM, Fujiwara K, Hauser MA, Scott BL, Pericak-Vance MA, Vance JM, Martin ER.  Fibroblast Growth Factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.  8th International Congress of Parkinson Disease and Movement Disorder Society Rome, Italy, June 13-17, 2004.

• Hulette CM, McLaurin AC, Ervin, JF, Vance JM, Schmechel DE.  Lewy Body Pathology in Parkinson Disease and Dementia with Lewy Bodies. American Association of Neuropathologists Annual Meeting.  Cleveland, OH, June 24-27, 2004.

• Hauser M,. Noureddine M, Walters RW, Hulette CM, Schmechel DE, Bembe ML, Stajich JM, Xu H, Martin ER, Scott BL, Stenger J, Li Y-J, Jensen R, Scherzer C, Gullans V, Vance JM. Expression analysis in Parkinson Disease (PD), progressive supranuclear palsy (PSP), and frontotemporal dementia with Parkinsonism.  54th Annual Meeting of the American Society of Human Genetics, Toronto, Canada. October 26-30, 2004.

• Noureddine MA, van der Walt JM, Hauser MA, Martin ER, Pearson J, Garcia-Blanco MA, Vance JM.  Molecular investigation of SNPs previously associated with Parkinson disease (PD) risk.  54th Annual Meeting of the American Society of Human Genetics, Toronto, Canada. October 26-30, 2004.

• Oliveira SA, Li Y-J, Qin XJ, Zuchner S, Noureddine MA, Hauser MA, Skelly T, Ebersviller S, Pericak-Vance MA, Vance JM.  Novel genes associated with risk and age-at-onset in Parkinson disease identified through iterative association mapping.  54th Annual Meeting of the American Society of Human Genetics, Toronto, Canada. October 26-30, 2004.

• Noureddine MA, van der Walt JM, Hauser MA, Martin ER, Pearson J, Garcia-Blanco MA, Vance JM.  Molecular investigation of SNPs previously associated with Parkinson disease (PD) risk.  6th Annual Udall Center Directors Meeting, Washington DC, November 30-December 2, 2004.

• Hauser MA, Noureddine M, Walters RW, Hulette CM, Schmechel DE, Bembe ML, Stajich JM, Xu H, Martin ER, Scott BL, Stenger J, Li Y-J, Jensen R, Scherzer C, Gullans S, Vance JM.  Expression analysis in Parkinson Disease (PD), progressive supranuclear palsy (PSP), and frontotemporal dementia with Parkinsonism.  6th Annual Udall Center Directors Meeting, Washington DC, November 30-December 2, 2004.

• Kang SJ, Scott WK, Noureddine MA, van der Walt JM, Vance JM, Martin ER.  Evaluation of Candidate Genes for Interaction in Parkinson Disease.  6th Annual Udall Center Directors Meeting, Washington DC, November 30-December 2, 2004.

• Oliveira SA, Li YJ, Qin XJ, Zuchner S, Noureddine MA, Hauser MA, Skelly T, Ebersviller S, Pericak-Vance MA, Vance JM.  Novel Genes Associated With Age-At-Onset In Parkinson Disease Identified Through Iterative Association Mapping.  7th International Conference AD/PD 2005, Sorrento, Italy.  March 9-13, 2005.

• Hauser MA, Noureddine M, Walters RW, Hulette CM, Schmechel DE, Bembe ML, Stajich JM, Xu H, Martin ER, Scott BL, Stenger, J, Li Y-J, Jensen R , Scherzer C, Gullans S, Vance JM.  Expression analysis in Parkinson Disease (PD), progressive supranuclear palsy (PSP), and frontotemporal dementia with Parkinsonism.  7th International Conference AD/PD 2005, Sorrento, Italy.  March 9-13, 2005.

• Hancock DB, Wheeler BS, Tegnell E, Hauser MA, Martin ER, Vance JM, Scott WK.  Association between iNOS and early-onset Parkinson Disease.  55th Annual Meeting of the American Society of Human Genetics, Salt Lake City, UT, October 24-29, 2005.

• Kang SJ, Scott WK, Li Y, Hauser MA, van der Walt JM, Fujiwara K, Vance JM, Martin ER.  Association of MAOB Polymorphism and Parkinson’s Disease.  55th Annual Meeting of the American Society of Human Genetics, Salt Lake City, UT, October 24-29, 2005.

• van der Walt JM, Noureddine M, Trimmer P, Bennett J, Stajich J, Scott B, Stacey M, Scott BK, Martin ER, Li, YJ, Hauser MA, Pericak-Vance MA, Vance JM.  Metabolic stress induces cell death in Parkinson disease cybrids and fibroblasts.  55th Annual Meeting of the American Society of Human Genetics, Salt Lake City, UT, October 24-29, 2005.

• Vance JM, Oliveira SA, Qin X, Huo X, Pericak-Vance MA, Li YJ.  Identification of translation initiation factor elF-2B gamma subunit (EIF2B3) on chromosome 1p for age at onset Parkinson disease: A potential Park10 gene.  55th Annual Meeting of the American Society of Human Genetics, Salt Lake City, UT, October 24-29, 2005.

• Hancock DB, Hauser MA, Li YJ, Martin ER, Vance JM, Scott WK. Association of iNOS in Parkinson disease and the modulating effect of smoking. First World Parkinson Congress, Washington, February 22-26, 2006, Movement Disorders 2006; 21(S13): P11.

• Martin ER, Kang S, Scott WK, Li YJ, Hauser MA, Vance JM. Association of MAOB polymorphism and Parkinson’s disease. First World Parkinson Congress, Washington, February 22-26, 2006, Movement Disorders 2006; 21(S13): P12.

• Kang SJ, Scott WK, Li Y-J, Hauser MA, Vance JM, Martin ER.  Association of MAOB Polymorphism and Parkinson’s Disease.  World Parkinson Congress, Washington D.C., February 22-26, 2006.

• Hancock DB, Martin ER, Li YJ, Scott WK. Gene-gene interaction methods for family-based case-control data. 56th Annual Meeting of the American Society of Human Genetics, New Orleans, Louisiana, October 9-13, 2006.

• Zhang L., Morris RW, Chung, RH, Martin ER, Li YJ. Likelihood ratio tests of association for X-linked QTL in family – based designs. 56th Annual Meeting of the American Society of Human Genetics, New Orleans, Louisiana, October 9-13, 2006.

• Chung RH, Morris RW, Zhang Li YJ, Martin ER. X-APL: A family-based association test for the X chromosome. (2315) 56th Annual Meeting of the American Society of Human Genetics, New Orleans, Louisiana, October 9-13, 2006.

• van der Walt JM, Scott WK, Mayhew G, Hauser MA, Li YJ, Fujiwara K, Vance JM, Martin ER.  Investigation of variants within dopamine pathway genes on risk of Parkinson's disease. 56th Annual Meeting of the American Society of Human Genetics, New Orleans, Louisiana, October 9-13, 2006.

• Hancock D.B., Martin E.R., Vance J.M., Scott W.K.  Interactions involving nitric oxide synthase genes and environmental risk factors in Parkinson's disease.  57th Annual Meeting of the American Society of Human Genetics.  San Diego, CA, October 23-27, 2007.

• Shehadeh L.A., Tsinoremas N.F., Vance J.M., Adi N., Papapetropoulos S.  THE RNA SPLICER GENE SRRM2 IS STRONGLY ASSOCIATED WITH PARKINSON DISEASE.  57th Annual Meeting of the American Society of Human Genetics.  San Diego, CA, October 23-27, 2007.

• Mayhew G.M., Liu Y., Hauser M.A., Li Y.J., Jewett R., Stajich J., Martin E.R., Vance J.M., Scott W.K.  Complete Genomic Screen in Familial Parkinson Disease.  57th Annual Meeting of the American Society of Human Genetics.  San Diego, CA, October 23-27, 2007.

• Wang G., van der Walt J., Mayhew G., Li Y., Züchner S., Scott W.K., Martin E., Vance J.M.  Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by over-expression of a-synuclein.  57th Annual Meeting of the American Society of Human Genetics.  San Diego, CA, October 23-27, 2007.

• Martin E., Gao X., Scott W., Wang G., Mayhew G., Vance J.  Gene-Gene Interaction between FGF20 and MAOB in Parkinson Disease.  57th Annual Meeting of the American Society of Human Genetics.  San Diego, CA, October 23-27, 2007.

• Vance, JM.  Commonalities in the genetics of Alzheimer’s Disease and Parkinson Disease.  Alzheimer's Association International Conference on Alzheimer's Disease.  Chicago, Illinois, July 26-31, 2008.